Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Stanley A. Nasraway"'
Autor:
Janis L. Breeze, Sharon Holewinski, Horacio Hojman, Sandra S. Arabian, Benjamin P Johnson, Stanley A. Nasraway, Nikolay Bugaev
Publikováno v:
The American Surgeon
BackgroundThe role of an acute care surgery (ACS) service during the COVID-19 pandemic is not well established.MethodsA retrospective review of the ACS service performance in an urban tertiary academic medical center. The study was performed between
Autor:
Roy Hayes, Stanley A. Nasraway, Guillermo E. Umpierrez, Paula Maurer, Douglas McComsey, James S. Krinsley, Sharon Holewinski
Publikováno v:
Mayo Clinic Proceedings. 92:1019-1029
Objective To describe the relationships among glycemic control, diabetes mellitus (DM) status, and mortality in critically ill patients from intensive care unit (ICU) admission to hospital discharge. Patients and Methods This is a retrospective inves
Autor:
David I. Bruns, Jean-Charles Preiser, James C. Boyd, Irl B. Hirsch, Eden Nohra, Laura J. Moore, Grant V. Bochicchio, Stanley A. Nasraway, James S. Krinsley, Kelly Bochicchio, Anthony P. Furnary
Publikováno v:
J Diabetes Sci Technol
Background: The use of near-continuous blood glucose (BG) monitoring has the potential to improve glycemic control in critically ill patients. The MANAGE IDE trial evaluated the performance of the OptiScanner (OS) 5000 in a multicenter cohort of 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e30e0b3dba42c2f3842fa36a3962b1
https://europepmc.org/articles/PMC8256060/
https://europepmc.org/articles/PMC8256060/
Autor:
Maura C Porto, John Adam Reich, Susan Hadley, Whitney Perry, David J. Tybor, Stanley A. Nasraway, Jana Hudcova, Debra D. Poutsiaka, David R. Snydman, Shira Doron
Publikováno v:
Open Forum Infectious Diseases
Background Sepsis definitions have evolved, but there is a lack of consensus over adoption of the most recent definition, Sepsis-3. We sought to compare Sepsis-2 and Sepsis-3 in the classification of patients with sepsis and mortality risk at 30 days
Publikováno v:
Journal of Hospital Administration. 10:29
Objective: Early reports demonstrate that patients with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection have high rates of hospitalization, intensive care unit (ICU) admission, and death. We sought to examine characteristics of
Publikováno v:
Critical Care Medicine. 49:68-68
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a global, devastating pandemic Early reports demonstrate that patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have high rates of hospitalization, intensive care
Autor:
James S, Krinsley, Paula, Maurer, Sharon, Holewinski, Roy, Hayes, Douglas, McComsey, Guillermo E, Umpierrez, Stanley A, Nasraway
Publikováno v:
Mayo Clinic proceedings. 92(7)
To describe the relationships among glycemic control, diabetes mellitus (DM) status, and mortality in critically ill patients from intensive care unit (ICU) admission to hospital discharge.This is a retrospective investigation of 6387 ICU patients wi
Autor:
Stanley A. Nasraway, Gail L. Kongable, My-Quyen Trieu, Keith Krystyniak, Ann Marie Melanson, Nicole M. Saur, Wayne Menzie, Hurley James P, Michael R. England, Jason Berlin
Publikováno v:
Journal of Diabetes Science and Technology. 8:945-950
Background: Stress hyperglycemia and hypoglycemia are associated with increased morbidity and mortality in the critically ill. Intermittent, random blood glucose (BG) measurements can miss episodes of hyper- and hypoglycemia. The purpose of this stud
Autor:
Rishi Rattan, Stanley A. Nasraway
Publikováno v:
Journal of Diabetes Science and Technology. 7:548-554
Since the development of intensive insulin therapy for the critically ill adult, tight glycemic control (TGC) has become increasingly complicated to apply and achieve. Software-guided (SG) algorithms for insulin dosing represent a new method to achie
Autor:
Barry D. Fuchs, Douglas B. Coursin, David Crippen, Ruth M. Kelleher, William T. Peruzzi, Philip D. Lumb, Dorrie K. Fontaine, Donald B. Chalfin, Gilles L. Fraser, William M. Coplin, H. Scott Bjerke, Eric Wittbrodt, Michael F. Masica, Stanley A. Nasraway, Paul E. Marik, Michael J. Murray, Richard R. Riker, Judith Jacobi
Publikováno v:
Critical Care Medicine. 30:119-141
Judith Jacobi, PharmD, FCCM, BCPS; Gilles L. Fraser, PharmD, FCCM; Douglas B. Coursin, MD; Richard R. Riker, MD; Dorrie Fontaine, RN, DNSc, FAAN; Eric T. Wittbrodt, PharmD; Donald B. Chalfin, MD, MS, FCCM; Michael F. Masica, MD, MPH; H. Scott Bjerke,